These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 25855785)
1. Circadian Clock Gene CRY2 Degradation Is Involved in Chemoresistance of Colorectal Cancer. Fang L; Yang Z; Zhou J; Tung JY; Hsiao CD; Wang L; Deng Y; Wang P; Wang J; Lee MH Mol Cancer Ther; 2015 Jun; 14(6):1476-87. PubMed ID: 25855785 [TBL] [Abstract][Full Text] [Related]
2. FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15. Li N; Lorenzi F; Kalakouti E; Normatova M; Babaei-Jadidi R; Tomlinson I; Nateri AS Oncotarget; 2015 Apr; 6(11):9240-56. PubMed ID: 25860929 [TBL] [Abstract][Full Text] [Related]
3. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma. Tu K; Yang W; Li C; Zheng X; Lu Z; Guo C; Yao Y; Liu Q Mol Cancer; 2014 May; 13():110. PubMed ID: 24884509 [TBL] [Abstract][Full Text] [Related]
4. Plk2 promotes tumor growth and inhibits apoptosis by targeting Fbxw7/Cyclin E in colorectal cancer. Ou B; Zhao J; Guan S; Wangpu X; Zhu C; Zong Y; Ma J; Sun J; Zheng M; Feng H; Lu A Cancer Lett; 2016 Oct; 380(2):457-466. PubMed ID: 27423313 [TBL] [Abstract][Full Text] [Related]
5. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc. Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179 [TBL] [Abstract][Full Text] [Related]
6. Rictor regulates FBXW7-dependent c-Myc and cyclin E degradation in colorectal cancer cells. Guo Z; Zhou Y; Evers BM; Wang Q Biochem Biophys Res Commun; 2012 Feb; 418(2):426-32. PubMed ID: 22285861 [TBL] [Abstract][Full Text] [Related]
7. Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance. Iwatsuki M; Mimori K; Ishii H; Yokobori T; Takatsuno Y; Sato T; Toh H; Onoyama I; Nakayama KI; Baba H; Mori M Int J Cancer; 2010 Apr; 126(8):1828-1837. PubMed ID: 19739118 [TBL] [Abstract][Full Text] [Related]
8. MALAT1 recruited the E3 ubiquitin ligase FBXW7 to induce CRY2 ubiquitin-mediated degradation and participated in trophoblast migration and invasion. Wu L; Liu Q; Fan C; Yi X; Cheng B J Cell Physiol; 2021 Mar; 236(3):2169-2177. PubMed ID: 32776544 [TBL] [Abstract][Full Text] [Related]
9. Loss of FBXW7 and accumulation of MCL1 and PLK1 promote paclitaxel resistance in breast cancer. Gasca J; Flores ML; Giráldez S; Ruiz-Borrego M; Tortolero M; Romero F; Japón MA; Sáez C Oncotarget; 2016 Aug; 7(33):52751-52765. PubMed ID: 27409838 [TBL] [Abstract][Full Text] [Related]
10. CRY2 and FBXL3 Cooperatively Degrade c-MYC. Huber AL; Papp SJ; Chan AB; Henriksson E; Jordan SD; Kriebs A; Nguyen M; Wallace M; Li Z; Metallo CM; Lamia KA Mol Cell; 2016 Nov; 64(4):774-789. PubMed ID: 27840026 [TBL] [Abstract][Full Text] [Related]
11. FBXW7 expression affects the response to chemoradiotherapy and overall survival among patients with oral squamous cell carcinoma: A single-center retrospective study. Arita H; Nagata M; Yoshida R; Matsuoka Y; Hirosue A; Kawahara K; Sakata J; Nakashima H; Kojima T; Toya R; Murakami R; Hiraki A; Shinohara M; Nakayama H Tumour Biol; 2017 Oct; 39(10):1010428317731771. PubMed ID: 29072128 [TBL] [Abstract][Full Text] [Related]
12. MYC is a critical target of FBXW7. Sato M; Rodriguez-Barrueco R; Yu J; Do C; Silva JM; Gautier J Oncotarget; 2015 Feb; 6(5):3292-305. PubMed ID: 25669969 [TBL] [Abstract][Full Text] [Related]
14. F-box and WD repeat domain-containing-7 (Fbxw7) protein targets endoplasmic reticulum-anchored osteogenic and chondrogenic transcriptional factors for degradation. Yumimoto K; Matsumoto M; Onoyama I; Imaizumi K; Nakayama KI J Biol Chem; 2013 Oct; 288(40):28488-502. PubMed ID: 23955342 [TBL] [Abstract][Full Text] [Related]
15. FBXW7 is involved in Aurora B degradation. Teng CL; Hsieh YC; Phan L; Shin J; Gully C; Velazquez-Torres G; Skerl S; Yeung SC; Hsu SL; Lee MH Cell Cycle; 2012 Nov; 11(21):4059-68. PubMed ID: 23095493 [TBL] [Abstract][Full Text] [Related]
16. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway. Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618 [TBL] [Abstract][Full Text] [Related]
17. MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer. Calcagno DQ; Freitas VM; Leal MF; de Souza CR; Demachki S; Montenegro R; Assumpção PP; Khayat AS; Smith Mde A; dos Santos AK; Burbano RR BMC Gastroenterol; 2013 Sep; 13():141. PubMed ID: 24053468 [TBL] [Abstract][Full Text] [Related]
18. FBXW7 negatively regulates ENO1 expression and function in colorectal cancer. Zhan P; Wang Y; Zhao S; Liu C; Wang Y; Wen M; Mao JH; Wei G; Zhang P Lab Invest; 2015 Sep; 95(9):995-1004. PubMed ID: 26097998 [TBL] [Abstract][Full Text] [Related]
19. E3 ubiquitin ligase FBXW7 enhances radiosensitivity of non-small cell lung cancer cells by inhibiting SOX9 regulation of CDKN1A through ubiquitination. Zhu H; Wang X; Zhou X; Lu S; Gu G; Liu C Lab Invest; 2022 Nov; 102(11):1203-1213. PubMed ID: 35840806 [TBL] [Abstract][Full Text] [Related]
20. MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells. Zhao J; Wang Y; Mu C; Xu Y; Sang J Oncogene; 2017 Aug; 36(35):5023-5034. PubMed ID: 28459460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]